about
[Treatment of recurrent Dupuytren's disease].Dupuytren's disease. The way forward?The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies.Dupuytren's contracture unfolded.The incidence of postoperative flare reaction and tissue complications in Dupuytren's disease using tension-free immobilization.Outcome of a multimodality approach to the management of idiopathic subglottic stenosis.Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.The "Jacobsen Flap" for the treatment of stages III-IV Dupuytren's disease: a review of 98 cases.Visual and computer software-aided estimates of Dupuytren's contractures: correlation with clinical goniometric measurements.Dupuytren's disease: current state of the artSafety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contractureA review of the classification of Dupuytren's disease.Skin involvement in Dupuytren's disease.Dupuytren's contracture: an audit of the outcomes of surgery.The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
P2860
Q30313481-C43F6507-E772-4D2E-B95A-D61C8EA15995Q33726264-B186F5A5-23C7-4B3C-81A9-DFB1A302E4B7Q34169030-50E10C42-8176-4EEC-A21F-8FBD3876C167Q34367026-8E65DC92-03EA-4F7F-8CA9-779EE4DB0DDBQ34534498-F81ED39F-7529-44A6-B738-C44CC1C37B9FQ34897362-75E65D94-DB56-4FDD-93C2-246FE21DFA8DQ36799416-72C6EA32-36BA-44F6-9938-54759EBBEA2BQ37245707-D828172D-C5A2-4921-87D2-5DD518F5A5AFQ37299495-5BDF85BB-A2EE-4036-B2E8-DAA853E6BCE3Q37303452-8AD404FF-DCD3-45B9-AE4D-B3EE0EBEFACBQ37358701-E1DF9926-EE29-495D-9B59-0898391055FAQ37591761-39167880-CC36-4D3A-9EE4-71D057D98FF7Q38201929-50B4CB2F-8C75-4433-AC5F-7ABB3C684E21Q38331364-EBA15B45-FED4-4CC1-96E0-F290BFDE6839Q53351010-9B1F175B-C3A4-40C6-8C67-081FFE0053D1Q54344145-B0E21FC2-66C3-4448-9BDB-4C92620320A1Q55038674-CF6675F4-871A-4F1D-A5D9-A7C1B54FC4ED
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Skin replacement in Dupuytren's disease.
@en
Skin replacement in Dupuytren's disease.
@nl
type
label
Skin replacement in Dupuytren's disease.
@en
Skin replacement in Dupuytren's disease.
@nl
prefLabel
Skin replacement in Dupuytren's disease.
@en
Skin replacement in Dupuytren's disease.
@nl
P2093
P1476
Skin replacement in Dupuytren's disease.
@en
P2093
P304
P356
10.1016/S0266-7681(97)80061-7
P577
1997-04-01T00:00:00Z